ciclesonide nasal aerosol

DRUG3 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

Allergic Rhinitis (AR)PARPerennial Allergic Rhinitis

Phase 1

A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler

CompletedNCT01371786

Sumitomo Pharma America, Inc.Allergic Rhinitis (AR)

Start: 2011-06-30End: 2011-08-31Updated: 2012-09-10

Phase 3

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

CompletedNCT01378429

Sumitomo Pharma America, Inc.PAR, Perennial Allergic Rhinitis

Start: 2011-07-31End: 2011-11-30Updated: 2014-05-26

Phase 4

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

CompletedNCT01654536

Sumitomo Pharma America, Inc.Perennial Allergic Rhinitis

Start: 2012-09-30End: 2013-07-31Updated: 2014-07-24